Chelonia Ongoing Projects

EXSCALATE4COV

This project is supported by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003551. Read more.

LIGATE

This project has received funding from the European High-Performance Computing Joint Undertaking Joint Undertaking (JU) under grant agreement No 956137. The JU receives support from the European Union’s Horizon 2020 research and innovation program and Italy, Sweden, Austria, Czech Republic, Switzerland. Read more.

MEDIATE (MOLECULAR DOCKING AT HOME)

In the framework of EXSCALATE4COV, this crowdsourcing initiative is aiming to find new therapeutic candidates against COVID together with research groups not already involved in other EU granted projects. Read more.

VIRALSEQ

Thanks to the data provided by GISAID, and to the analysis on the SARS-CoV-2 sequences that we are carrying out within the EXSCALATE4COV project, we want to collect essential information and make it easily usable and accessible to the scientific community and beyond. Read more.

AI-MICROBIOME 

Microbiome diagnostics highlighting the health effect and robustness of patient's microbiome. Personalized dietary supplements improving microbiome composition to reduce the risk of selected diseases.

VACCINES

HLA and innate-immunity gene variants as severity predictors of COVID-19: an Italian multi-centric perspective association study.

  • LinkedIn
  • Facebook
  • Twitter

The company is registered in Lugano (Canton Tessin, Switzerland) since 2002 with the Nr. CHE-109.905.540  ©2021 by Chelonia S.A.